本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

174.75
-0.1350-0.08%
盘后174.750.00000.00%16:19 EDT
成交量:31.43万
成交额:5,460.50万
市值:105.82亿
市盈率:-27.76
高:177.00
开:176.00
低:171.49
收:174.89
数据加载中...
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]